Novocell Inc., a San Diego-based stem cell engineering company, has raised $25 million in Series C funding. Johnson & Johnson Development Corp. led the deal, and was joined by return backers Sanderling Ventures, Asset Management Co.and Pacific Horizon Ventures. Novocell has now raised around $74 million in total VC funding since its 1999 inception.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.